Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients

Table 4

Multivariable Cox regression models for overall graft loss in recipients with HCV positive liver disease.

	Pre-/intra-operative model			Early post-operative model
	HR	(95% CI)	P	HR	(95% CI)	P
Donor ICU stay (days)	1.078	0.983-1.182	0.112	0.967	0.855-1.094	0.596
Graft cold ischemia time (minutes)	1.006	1.003-1.010	<0.001	1.004	1.000-1.008	0.050
Graft warm ischemia time (minutes)	1.011	0.999-1.024	0.073	1.017	0.998-1.035	0.077
IRI score, categorical (severe vs mild/moderate)^§				4.485	1.755-11.459	0.002
IPGF (yes vs no)				5.074	1.499-17.170	0.009
EAD (yes vs no)				0.921	0.370-2.292	0.860

ICU, intensive care unit; IRI, histological ischemia/reperfusion injury; IPGF, initial poor graft function; EAD, early allograft dysfunction.
§Available in only 55 patients.